156 related articles for article (PubMed ID: 1712541)
1. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.
Traweek ST; Kandalaft PL; Mehta P; Battifora H
Am J Clin Pathol; 1991 Jul; 96(1):25-31. PubMed ID: 1712541
[TBL] [Abstract][Full Text] [Related]
2. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
4. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors.
Cohen PR; Rapini RP; Farhood AI
J Cutan Pathol; 1993 Feb; 20(1):15-20. PubMed ID: 7682226
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
8. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of ERG, Fli-1, CD34, CD31 and Fâ…§RAg expression in hepatic malignant vascular tumors].
Wang ZB; An XJ; Deng JF; Liu JH; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688
[No Abstract] [Full Text] [Related]
10. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
[TBL] [Abstract][Full Text] [Related]
11. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
12. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
14. Assessment of diagnostic utility of anti-CD34 in soft tissue tumors.
Park HR; Park YK
J Korean Med Sci; 1995 Dec; 10(6):436-41. PubMed ID: 8924229
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin expression in epithelioid vascular neoplasms.
Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of human hemangiosarcomas and hemangiomas.
Liu L; Kakiuchi-Kiyota S; Arnold LL; Johansson SL; Wert D; Cohen SM
Hum Pathol; 2013 Oct; 44(10):2302-11. PubMed ID: 24054722
[TBL] [Abstract][Full Text] [Related]
18. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
19. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
20. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation.
DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR
J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
